Katie Stockton breaks down the technical outlook on this telehealth name.
Get this delivered to your inbox, and more info about our products and services.
David Keller breaks down the technicals on this biotech giant.
Chart analyst Frank Cappelleri breaks down the technical outlook on the biotech stock.
Chart analyst Katie Stockton breaks down the technical outlook of this Chinese tech name.
Frank Holland breaks down what traders are watching ahead of the new session.
Chart analyst Frank Cappelleri goes through the charts that make this stock an attractive play.
The bank upgraded the digital platform for medical professionals to a strong buy from outperform.
